Alterations in nitric oxide synthase activity and expression in submandibular glands of nod mice
The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the neural control of the secretory process in the targe...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Academic Press Inc.
2001
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12362caa a22011657a 4500 | ||
|---|---|---|---|
| 001 | PAPER-1935 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203116.0 | ||
| 008 | 190411s2001 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0034793757 | |
| 024 | 7 | |2 cas |a nitric oxide synthase, 125978-95-2 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a CLIIF | ||
| 100 | 1 | |a Rosignoli, F. | |
| 245 | 1 | 0 | |a Alterations in nitric oxide synthase activity and expression in submandibular glands of nod mice |
| 260 | |b Academic Press Inc. |c 2001 | ||
| 270 | 1 | 0 | |m Pérez Leirós, C.; Departamento de Quimica Biologica, Ciudad Universitaria, Pabellón II, 4 piso, (1428) Buenos Aires, Argentina; email: cpleiros@qb.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Strand, V., Talal, N., Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) (1980) Bull. Rheum. Dis., 92, pp. 212-226 | ||
| 504 | |a Jacobsson, L.T.H., Manthorpe, R., Epidemiology of Sjögren's syndrome (1995) Rheumatol. Eur., 24, pp. 46-47 | ||
| 504 | |a Fox, R.I., Michelson, P., Approaches to the treatment of Sjögren's syndrome (2000) J. Rheumatol., 27, pp. 15-21 | ||
| 504 | |a Manthorpe, R., Asmussen, K., Oxholm, P., Primary Sjögren's syndrome criteria, clinical features and disease activity (1997) J. Rheumatol., 24 (SUPPL. 50), pp. 8-11 | ||
| 504 | |a Fox, R.I., Maruyama, T., Pathogenesis and treatment of Sjögren's syndrome (1997) Curr. Opin. Rheumatol., 9, pp. 393-399 | ||
| 504 | |a Bacman, S., Sterin-Borda, L., Camusso, J.J., Arana, R., Hubscher, O., Borda, E., Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome (1996) Clin. Exp. Immunol., 104, pp. 454-459 | ||
| 504 | |a Bacman, S., Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome (1998) Invest. Opthalmol. Vis. Sci., 39, pp. 151-156 | ||
| 504 | |a Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies (1999) Clin. Immunol., 90, pp. 190-195 | ||
| 504 | |a Miyagawa, J., Ultrastructural immunocytochemical submandibulitis in the non-obese diabetic (NOD) mouse (1986) Virchows Arch. (Cell. Pathol.), 51, pp. 215-225 | ||
| 504 | |a Humphreys-Beher, M.G., Hu, Y., Nakagawa, Y., Wang, P.L., Purushotham, K.R., Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome (1994) Adv. Exp. Med. Biol., 350, pp. 631-637 | ||
| 504 | |a Yamano, S., Atkinson, J.C., Baum, B.J., Fox, P.C., Salivary gland cytokine expression in NOD and normal BALB/c mice (1999) Clin. Immunol., 92, pp. 265-275 | ||
| 504 | |a Yamamoto, H., Sims, N.E., Macauley, S.P., Nguyen, K.H.T., Nakagawa, Y., Humphreys-Beher, M.G., Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation (1996) Clin. Immunol. Immunopathol., 78, pp. 245-255 | ||
| 504 | |a Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide physiology, pathophysiology and pharmacology (1991) Pharmacol. Rev., 43, pp. 109-142 | ||
| 504 | |a Nathan, C., Inducible nitric oxide synthase: What difference does it make? (1997) J. Clin. Invest., 100, pp. 2417-2423 | ||
| 504 | |a Edwards, A.V., Garrett, J.R., Nitric oxide-related vasodilator responses to sympathetic stimulation of the submandibular gland in the cat (1993) J. Physiol., 464, pp. 379-392 | ||
| 504 | |a Lomniczi, A., Suburo, A.M., Elverdin, J.C., Mastronardi, C.A., Diaz, S., Rettori, V., McCann, S.M., Role of nitric oxide in salivary secretion (1998) Neuroimmunomodulation, 5, pp. 226-233 | ||
| 504 | |a Lohinai, Z., Burghardt, B., Zelles, T., Varga, G., Nitric oxide modulates salivary amylase and fluid, but not epidermal growth factor secretion in conscious rats (1999) Life Sci., 64, pp. 953-963 | ||
| 504 | |a Nathan, C., Xie, Q.W., Regulation of biosynthesis of nitric oxide (1994) J. Biol. Chem., 269, pp. 13725-13728 | ||
| 504 | |a Förstermann, U., Boissel, J.P., Kleinert, H., Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III) (1998) FASEB J., 12, pp. 773-790 | ||
| 504 | |a Perez Leiros, C., Goren, N., Sterin-Borda, L., Lustig, L., Borda, E.S., Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies (1994) Clin. Auton. Res., 4, pp. 249-255 | ||
| 504 | |a Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275 | ||
| 504 | |a Bernfeld, P., Amylase, alpha and beta (1955) Methods Enzymol., 1, pp. 149-158 | ||
| 504 | |a Perez Leiros, C., Rosignoli, F., Genaro, A.M., Sales, M.E., Sterin-Borda, L., Borda, E.S., Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands (2000) J. Auton. Nerv. Syst., 79, pp. 99-107 | ||
| 504 | |a Davel, L., Eiján, A.M., Sales, M.E., Español, A., D'Agostino, A., Diccardo, I., Lustig, E.S., Jasnis, M.A., Nitric oxide and prostaglandin E2 regulate the biological activity of tumor draining lymph nodes in a murine mammary adenocarcinoma (2000) Nitric Oxide Biol. Chem., , in press | ||
| 504 | |a Murthy, K.S., Zhang, K.-M., Jin, J.G., Grider, J.R., Makhlouf, G.M., VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells (1993) Am. J. Physiol., 265, pp. G660-G671 | ||
| 504 | |a Kontinnen, Y.T., Platts, L.A.M., Tuominen, S., Eklund, K.K., Santavirta, N., Törnwall, J., Sorsa, T., Polak, J.M., Role of nitric oxide in Sjögren's syndrome (1997) Arthritis Rheum., 40, pp. 875-883 | ||
| 504 | |a Lohinai, Z., Szekely, A.D., Soos, L., Feher, E., Distribution of nitric oxide synthase containing elements in the feline submandibular gland (1995) Neurosci. Lett., 192, pp. 9-12 | ||
| 504 | |a Hu, Y., Nakagawa, Y., Purshotham, K., Humphreys-Beher, M.G., Functional changes in salivary glands of autoimmune disease-prone NOD mice (1992) Am. J. Physiol., 263, pp. E607-E614 | ||
| 504 | |a Robinson, C.P., Yamamoto, H., Peck, A.B., Humphreys-Beher, M.G., Genetically programmed development of salivary gland abnormalities in the NOD-scid mouse: A potential trigger for sialoadenitis of NOD mice (1996) Clin. Immunol. Immunopathol., 79, pp. 50-59 | ||
| 504 | |a Shaw, P., Sordat, B., Schibler, U., Developmental coordination of α amylase and PSP gene expression during mouse parotid gland differentiation is controlled posttranscriptionally (1986) Cell, 47, pp. 107-112 | ||
| 504 | |a Rosignoli, F., Pérez Leirós, C., Activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat parotid (2000) Br. J. Pharmacol., 131, p. 55 | ||
| 504 | |a Said, S., VIP as a modulator of lung inflammation and airway constriction (1991) Am. Rev. Respir. Dis., 143, pp. 22-24 | ||
| 504 | |a Yamamoto, H., Ishibashi, K., Nakagawa, Y., Maeda, N., Zeng, T., Robinson, C.P., Oxford, G.E., Humphreys-Beher, M.G., Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis (1997) Scand. J. Immunol., 45, pp. 55-61 | ||
| 504 | |a Roitt, I.M., Brostoff, J., Male, D., Autoimmunity and autoimmune disease (1998) Immunology, pp. 367-380. , Mosby, London | ||
| 504 | |a Hu, Y., Purushotham, K.R., Wang, P.L., Dawson, R., Humphreys-Beher, M.G., Down-regulation of β adrenergic receptors and signal transduction response in salivary glands of NOD mice (1994) Am. J. Physiol., 266, pp. G433-G443 | ||
| 504 | |a Nguyen, K.H.T., Brayer, J., Cha, S., Diggs, S., Yasunari, U., Hilal, G., Peck, A.B., Humphreys-Beher, M.G., Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice (2000) Arthritis Rheum., 43, pp. 2297-2306 | ||
| 504 | |a Goin, J.C., Perez Leiros, C., Borda, E., Sterin-Borda, L., Interaction of human chagasic IgG with the second extracellular loop of the human Heart muscarinic acetylcholine receptor: Functional and pathological implications (1997) FASEB J., 10, pp. 77-83 | ||
| 504 | |a Perez Leiros, C., Sterin-Borda, L., Borda, E., β-adrenergic cardiac antibody in autoimmune myocarditis (1989) Autoimmunity, 2, pp. 223-234 | ||
| 504 | |a Bijlsma, J.W.J., Cutolo, M., Masi, A.T., Chikanza, I.C., The neuroendocrine immune basis of rheumatic diseases (1999) Immunol. Today, 20, pp. 298-301 | ||
| 520 | 3 | |a The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the neural control of the secretory process in the target organ. The purpose of this study was to explore putative alterations in the activity and expression of nitric oxide synthase (NOS) in submandibular glands of NOD mice in relation to parotid glands and unrelated tissues. Here we report that NOD mice with incipient signs of secretory dysfunction presented a marked decrease in basal and vasoactive intestinal peptide (VIP)-stimulated NOS activity and a differential expression of NOS I in submandibular glands compared to control BALB/c mice. Similar alterations in NOS I were found in parotid glands but not in brain or spleen of NOD mice. No differences between NOD and controls appeared in NOS II and NOS III expression in any of the tissues studied. © 2001 Academic Press. |l eng | |
| 536 | |a Detalles de la financiación: Ministerio de Salud de la Nación, MSAL | ||
| 536 | |a Detalles de la financiación: Fundación Alberto J. Roemmers | ||
| 536 | |a Detalles de la financiación: This work was supported by Grant “Beca Ramón Carrillo–Arturo Oñativia” (2000) from the Ministerio de Salud of Argentina and Grant 2000–2002 from Fundación Alberto J. Roemmers. We wish to thank Drs. Graciela Lammel and Adela Rosenkranz for helpful advice regarding NOD mice management and Mrs. Micaela Ricca and Marianela Lewicky for their expert technical assistance. | ||
| 593 | |a Departamento De Química Biológica, Facultad De Ciencias Exactas Y Naturales, Universidad De Buenos Aires-CONICET, Buenos Aires, Argentina | ||
| 593 | |a Facultad De Ciencias Exactas Y Naturales, Universidad De Buenos Aires-CONICET, Centro De Estudios Farmacológicos Y Botánicos-CONICET, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a AUTOIMMUNE SIALADENITIS |
| 690 | 1 | 0 | |a NITRIC OXIDE SYNTHASE |
| 690 | 1 | 0 | |a NOD |
| 690 | 1 | 0 | |a NOS ISOFORMS |
| 690 | 1 | 0 | |a SALIVARY GLANDS |
| 690 | 1 | 0 | |a VIP |
| 690 | 1 | 0 | |a AUTOANTIBODY |
| 690 | 1 | 0 | |a NITRIC OXIDE SYNTHASE |
| 690 | 1 | 0 | |a ANIMAL EXPERIMENT |
| 690 | 1 | 0 | |a ANIMAL MODEL |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a AUTOIMMUNITY |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a ENZYME ACTIVITY |
| 690 | 1 | 0 | |a FLOW RATE |
| 690 | 1 | 0 | |a INFLAMMATORY CELL |
| 690 | 1 | 0 | |a LYMPHOCYTE PROLIFERATION |
| 690 | 1 | 0 | |a MOUSE |
| 690 | 1 | 0 | |a NEUROTRANSMITTER RELEASE |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a SALIVATION |
| 690 | 1 | 0 | |a SIALOADENITIS |
| 690 | 1 | 0 | |a SJOEGREN SYNDROME |
| 690 | 1 | 0 | |a SUBMANDIBULAR GLAND |
| 690 | 1 | 0 | |a TARGET CELL |
| 690 | 1 | 0 | |a TRANSLATION REGULATION |
| 700 | 1 | |a Goren, N.B. | |
| 700 | 1 | |a Pérez Leirós, C. | |
| 773 | 0 | |d Academic Press Inc., 2001 |g v. 101 |h pp. 86-93 |k n. 1 |p Clin. Immunol. |x 15216616 |w (AR-BaUEN)CENRE-4216 |t Clinical Immunology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034793757&doi=10.1006%2fclim.2001.5097&partnerID=40&md5=016f50c094fcb352ce99fe627a9d382c |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1006/clim.2001.5097 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_15216616_v101_n1_p86_Rosignoli |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15216616_v101_n1_p86_Rosignoli |y Registro en la Biblioteca Digital |
| 961 | |a paper_15216616_v101_n1_p86_Rosignoli |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 62888 | ||